Trial Profile
A Prospective, Multi-Center, Randomized, Double-Masked, Safety, Tolerability and Efficacy Study of Four Iontophoretic Doses of Dexamethasone Phosphate Ophthalmic Solution in Patients With Non-Infectious Anterior Segment Uveitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Sep 2022
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Anterior uveitis
- Focus Therapeutic Use
- Sponsors EyeGate Pharma; Kiora Pharmaceuticals
- 22 May 2014 New trial record